Drug Efflux Transporters Are Overexpressed in Short-Term Tamoxifen-Induced MCF7 Breast Cancer Cells

Tamoxifen is the first line drug used in the treatment of estrogen receptor-positive (ER+) breast cancer. The development of multidrug resistance (MDR) to tamoxifen remains a major challenge in the treatment of cancer. One of the mechanisms related to MDR is decrease of drug influx via overexpressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Krisnamurti, Desak Gede Budi, Louisa, Melva, Anggraeni, Erlia, Wanandi, Septelia Inawati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769734/
https://www.ncbi.nlm.nih.gov/pubmed/26981116
http://dx.doi.org/10.1155/2016/6702424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769734/
https://www.ncbi.nlm.nih.gov/pubmed/26981116
http://dx.doi.org/10.1155/2016/6702424

Ejemplares similares